Parabase Genomics
Biotechnology, Genetics, Health Care, Health Diagnostics
Founded in 2009-01-01
Hardwick, Massachusetts, United States
For Profit
About Parabase Genomics
Parabase Genomics is a privately held molecular diagnostics company focused on changing the way newborns and children with genetic disorders are diagnosed and treated. The Company’s NewbornDx™ test is designed to guide the differential diagnosis of common symptomology found in neonates. It allows a physician to utilize one test to provide an accurate molecular profile on 500+ newborn related genes using dried blood spots within 10 days. Physicians no longer need to depend on severe phenotypes to nominate a single gene test for a given disorder.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: 13 active products
Financial Information
- Estimated Revenue: Less than $1M
- Total Funding: 2970000 USD
- Last Funding: 2000000 USD (Series B)
- Funding Status: Early Stage Venture
Technology Stack
Parabase Genomics actively uses 13 products in their tech stack.
Market Presence
Industries: Biotechnology, Genetics, Health Care, Health Diagnostics
Headquarters: Hardwick, Massachusetts, United States